The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

Greetings and welcome to the W.W. Grainger fourth quarter 2024 earnings conference call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to ...